Myocardial perfusion

Noninvasive cardiac magnetic resonance (CMR) imaging has progressed rapidly over the past few years and will most likely become an integral part of the diagnostic workup of patients with known or suspected coronary artery disease (CAD). In this article the rationale for using perfusion-CMR is discussed, followed by a summary of current state-of-the-art perfusion-CMR techniques that addresses pharmacological stress, monitoring, pulse sequences, and doses of contrast media (CM) for first-pass studies. In the second part, unresolved aspects of perfusion-CMR, such as the lack of fully established and validated imaging protocols, are discussed. The optimum pulse sequence parameters, required cardiac coverage, analysis algorithms, criteria for data quality, and other aspects remain to be defined. Furthermore, since expertise in perfusion-CMR is not yet widely available, training of physicians and technicians to perform perfusion-CMR according to recognized standards is an important future requirement. In the last part of the review, some ideas are proposed to improve the management of patients with known or suspected CAD. This involves making a shift from a "reactive" strategy, in which patients are typically approached when they are symptomatic, to an "active" strategy, in which perfusion-CMR is performed for early detection of high-risk patients so that revascularizations can be performed before potentially deadly infarcts occur. An ideal test for such an active strategy would be highly accurate, reliable, safe (and thus repeatable), and affordable. Large multicenter trials have shown that in experienced centers perfusion-CMR is reliable and repeatable, and it is hoped that future studies will demonstrate its cost-effectiveness as well.     

MRI of meniscal lesions: soft-copy (PACS) and hard-copy evaluation versus reviewer experience

OBJECTIVE: The purpose of our study was to compare diagnostic performance, reviewer confidence, and time requirements in the MRI diagnosis of meniscal tears for three types of reviewers and two types of image documentations (PACS vs hard copies). MATERIALS AND METHODS: An experienced musculoskeletal radiologist (reviewer 1), a fellow in musculoskeletal radiology (reviewer 2), and a junior staff member in orthopedic surgery (reviewer 3) evaluated MR images displayed on PACS monitors and hard copies independently and in a blinded fashion with regard to the presence or absence of meniscal tears. Seventy-one patients (mean age, 45.4 years; range, 16-80 years) were consecutively included if they had undergone both MRI of the knee and arthroscopy within 4 months. Arthroscopy was the standard of reference. Evaluation time and the reviewer's confidence in his or her diagnosis (Visual Analogue Scale, possible values of 0-100) were determined. RESULTS: Accuracies, sensitivities, and specificities in diagnosing meniscal tears were 80-87%, 63-85%, and 87-93% for soft copies and 82-85%, 64-76%, and 87-94.0%, respectively, for hard copies. Intrareviewer differences between PACS and hard copies were not significant for any of the three reviewers (McNemar tests). Reviewer 3 was less sensitive but more specific in the diagnosis of meniscal tears than reviewers 1 and 2. This difference was significant for both the PACS and hard copies. The reviewers' confidence in their diagnoses and evaluation times were not significantly different for PACS and hard copies (analysis of variance with Bonferroni post hoc analysis). CONCLUSION: Differences in the diagnostic performance of suspected meniscal tears depend on reviewer experience rather than on the type of documentation.     

Early gene expression changes by Epstein‐Barr virus infection of B‐cells indicate CDKs and survivin as therapeutic targets for post‐transplant lymphoproliferative diseases

Lymphoproliferative diseases (LPDs) associated with Epstein‐Barr virus (EBV) infection cause significant morbidity and mortality in bone marrow and solid organ transplant recipients. To gain insight into LPD pathogenesis and to identify potential effective therapeutic approaches, we investigated early molecular events leading to B‐cell transformation by gene expression profiling of EBV‐infected B‐cells from tonsils by Affymetrix microarray 72 hr postinfection when the B‐cells hyperproliferation phase starts. Cell cycle and apoptosis were the most significantly affected pathways and enriched gene sets. In particular, we found significantly increased expression of cyclin‐dependent kinase (CDK)1 and CCNB1 (cyclin B1) and of one of their downstream targets BIRC5 (survivin). Importantly, the strong upregulation of the antiapoptotic protein survivin was confirmed in lymphoblastoid cell lines (LCLs) and 71% of EBV‐positive post‐transplant EBV‐LPD lesions scored positive for survivin. The validity of early transforming events for the identification of therapeutic targets for EBV‐LPD was confirmed by the marked antiproliferative effect of the CDK inhibitor flavopiridol on LCLs and by the strong induction of apoptosis by survivin inhibition with YM155 or terameprocol. Our results suggest that targeting of CDKs and/or survivin in post‐transplant EBV‐LPD by specific inhibitors might be an important approach to control and eliminate EBV‐transformed B‐cells that should be further considered.     

A forgotten facial nerve tumour: granular cell tumour of the parotid and its implications for treatment

We present a rare case of a facial nerve granular cell tumour in the right parotid gland, in a 10-year-old boy. A parotid or neurogenic tumour was suspected, based on magnetic resonance imaging. Intra-operatively, strong adhesions to surrounding structures were found, and a midfacial nerve branch had to be sacrificed for complete tumour removal. Recent reports verify that granular cell tumours arise from Schwann cells of peripheral nerve branches. The rarity of this tumour within the parotid gland, its origin from peripheral nerves, its sometimes misleading imaging characteristics, and its rare presentation with facial weakness and pain all have considerable implications on the surgical strategy and pre-operative counselling. Fine needle aspiration cytology may confirm the neurogenic origin of this lesion. When resecting the tumour, the surgeon must anticipate strong adherence to the facial nerve and be prepared to graft, or sacrifice, certain branches of this nerve.     

Current variables,definitions and endpoints of the European Cardiovascular Magnetic Resonance Registry

Background

Cardiovascular Magnetic Resonance (CMR) is increasingly used in daily clinical practice. However, little is known about its clinical utility such as image quality, safety and impact on patient management. In addition, there is limited information about the potential of CMR to acquire prognostic information.

Methods

The European Cardiovascular Magnetic Resonance Registry (EuroCMR Registry) will consist of two parts: 1) Multicenter registry with consecutive enrolment of patients scanned in all participating European CMR centres using web based online case record forms. 2) Prospective clinical follow up of patients with suspected coronary artery disease (CAD) and hypertrophic cardiomyopathy (HCM) every 12 months after enrolment to assess prognostic data.

Conclusion

The EuroCMR Registry offers an opportunity to provide information about the clinical utility of routine CMR in a large number of cases and a diverse population. Furthermore it has the potential to gather information about the prognostic value of CMR in specific patient populations.     

Masthead,Volume 65, Issue 1

At sufficiently high Larmor frequencies, traveling electromagnetic waves along a magnet bore can be used for remote magnetic resonance excitation and detection, effectively using the bore as a waveguide. So far, this approach has relied only on the lowest waveguide modes and thus has not supported multiple‐channel operation for radiofrequency shimming and parallel imaging. In this work, this limitation is addressed by establishing a larger number of propagating modes and tapping their spatial field diversity with multiple waveguide ports. The number of available modes is increased by loading with dielectric inserts; the ports are implemented by stub and loop couplers at the end of a waveguide extension. The resulting traveling‐wave array, operated at 298 MHz in a 7T whole‐body magnet, is shown to enable radiofrequency shimming as well as parallel imaging with commonly used acceleration factors. The last part of the study concerns the amount of dielectric loading that is required. For the given Larmor frequency and bore dimensions, it is found that rather few water‐filled inserts, occupying ～5% of the bore cross‐section, are sufficient for effective parallel imaging. Magn Reson Med, 2011. © 2011 Wiley‐Liss, Inc.